Eur Rev Med Pharmacol Sci 2020; 24 (13): 7215-7215
DOI: 10.26355/eurrev_202007_21866

LncRNA CASC15 promotes migration and invasion in prostate cancer via targeting miR-200a-3p

C. Zhang, G.-X. Wang, B. Fu, X.-C. Zhou, Y. Li, Y.-Y. Li

Department of Urology, The First Affiliated Hospital of Nanchang University, Nanchang, China.


Since this article has been suspected of research misconduct and the corresponding authors did not respond to our request to prove originality of data and figures, “LncRNA CASC15 promotes migration and invasion in prostate cancer via targeting miR-200a-3p, by C. Zhang, G.-X. Wang, B. Fu, X.-C. Zhou, Y. Li, Y.-Y. Li, published in Eur Rev Med Pharmacol Sci 2019; 23 (19): 8303-8309–DOI: 10.26355/eurrev_201910_19141–PMID: 31646560” has been withdrawn.

The Publisher apologizes for any inconvenience this may cause.

LncRNA CASC15 promotes migration and invasion in prostate cancer via targeting miR-200a-3p

 

Free PDF Download

To cite this article

C. Zhang, G.-X. Wang, B. Fu, X.-C. Zhou, Y. Li, Y.-Y. Li
LncRNA CASC15 promotes migration and invasion in prostate cancer via targeting miR-200a-3p

Eur Rev Med Pharmacol Sci
Year: 2020
Vol. 24 - N. 13
Pages: 7215-7215
DOI: 10.26355/eurrev_202007_21866